Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 1
1955 1
1956 2
1957 1
1958 2
1959 1
1965 6
1966 4
1967 3
1968 5
1969 11
1970 6
1971 11
1972 13
1973 8
1974 5
1975 12
1976 5
1977 8
1978 11
1979 9
1980 18
1981 17
1982 14
1983 24
1984 20
1985 19
1986 21
1987 19
1988 22
1989 24
1990 18
1991 19
1992 24
1993 20
1994 26
1995 25
1996 33
1997 28
1998 33
1999 33
2000 34
2001 38
2002 34
2003 54
2004 47
2005 47
2006 61
2007 59
2008 82
2009 86
2010 89
2011 91
2012 108
2013 101
2014 128
2015 112
2016 117
2017 129
2018 172
2019 138
2020 149
2021 142
2022 111
2023 99
2024 40

Text availability

Article attribute

Article type

Publication date

Search Results

2,572 results

Results by year

Filters applied: . Clear all
Page 1
EDITORIAL.
Kennedy DW. Kennedy DW. Int Forum Allergy Rhinol. 2015 Dec;5(12):1083-4. doi: 10.1002/alr.21692. Int Forum Allergy Rhinol. 2015. PMID: 26769189 No abstract available.
Cannabinoid Cancer Biology and Prevention.
McAllister SD, Abood ME, Califano J, Guzmán M. McAllister SD, et al. J Natl Cancer Inst Monogr. 2021 Nov 28;2021(58):99-106. doi: 10.1093/jncimonographs/lgab008. J Natl Cancer Inst Monogr. 2021. PMID: 34850900 Review.
Importantly, evidence is presented demonstrating when cannabinoids may be contraindicated as a treatment for cancer, as in the case of human papilloma virus-meditated oropharynx cancer or potentially other p38 MAPK pathway-driven cancers. Finally, it is discussed that a ke …
Importantly, evidence is presented demonstrating when cannabinoids may be contraindicated as a treatment for cancer, as in the case of human …
Immunotherapy against cancer-related viruses.
Tashiro H, Brenner MK. Tashiro H, et al. Cell Res. 2017 Jan;27(1):59-73. doi: 10.1038/cr.2016.153. Epub 2016 Dec 23. Cell Res. 2017. PMID: 28008927 Free PMC article. Review.
To date, eight viruses have been shown to contribute to the development of human cancers, including Epstein-Barr virus (EBV), Hepatitis B and C viruses, and Human papilloma virus, among others. These DNA and RNA viruses produce oncogenic effects through distinct mechanisms …
To date, eight viruses have been shown to contribute to the development of human cancers, including Epstein-Barr virus (EBV), Hepatitis B an …
The Effect of a Web-Based Cervical Cancer Survivor's Story on Parents' Behavior and Willingness to Consider Human Papillomavirus Vaccination for Daughters: Randomized Controlled Trial.
Suzuki Y, Sukegawa A, Ueda Y, Sekine M, Enomoto T, Melamed A, Wright JD, Miyagi E. Suzuki Y, et al. JMIR Public Health Surveill. 2022 May 25;8(5):e34715. doi: 10.2196/34715. JMIR Public Health Surveill. 2022. PMID: 35421848 Free PMC article. Clinical Trial.
Participants were randomly assigned (1:1) to see a short film on a cervical cancer survivor or nothing, stratified by sex (male vs female) and willingness for HPV vaccination prior to randomization (yes vs no). ...Furthermore, this narrative approach to parents does …
Participants were randomly assigned (1:1) to see a short film on a cervical cancer survivor or nothing, stratified by sex (male vs fe …
Advances in Radiation Oncology: What to Consider.
Hegde JV, Chen AM, Chin RK. Hegde JV, et al. Otolaryngol Clin North Am. 2017 Aug;50(4):755-764. doi: 10.1016/j.otc.2017.03.011. Epub 2017 May 17. Otolaryngol Clin North Am. 2017. PMID: 28527523 Review.
This review includes recent and ongoing studies that are potentially practice changing, including improvements in intensity-modulated radiotherapy planning, the use of deintensified regimens in the human papilloma virus-related setting, and adjuvant therapy after transoral …
This review includes recent and ongoing studies that are potentially practice changing, including improvements in intensity-modulated radiot …
Management of inverted papilloma: review.
Attlmayr B, Derbyshire SG, Kasbekar AV, Swift AC. Attlmayr B, et al. J Laryngol Otol. 2017 Apr;131(4):284-289. doi: 10.1017/S0022215117000172. Epub 2017 Feb 9. J Laryngol Otol. 2017. PMID: 28179032 Review.
BACKGROUND: Inverted papilloma is the most common benign tumour affecting the nose. There is a high rate of recurrence and a potential of malignant transformation. ...There may be some benefit to the use of attachment-oriented surgery and frozen sections. Multi-centred …
BACKGROUND: Inverted papilloma is the most common benign tumour affecting the nose. There is a high rate of recurrence and a potentia …
Primary ovarian insufficiency and human papilloma virus vaccines: a review of the current evidence.
Christianson MS, Wodi P, Talaat K, Halsey N. Christianson MS, et al. Am J Obstet Gynecol. 2020 Mar;222(3):239-244. doi: 10.1016/j.ajog.2019.08.045. Epub 2019 Aug 31. Am J Obstet Gynecol. 2020. PMID: 31479634 Review.
Human papilloma virus is the primary causative agent for cervical cancer, and vaccination is the primary means of preventing anogenital cancers caused by human papilloma virus infection. ...Public concerns regarding safety of human papilloma virus vaccines ha …
Human papilloma virus is the primary causative agent for cervical cancer, and vaccination is the primary means of preventing anogenit …
Tacrolimus in dermatology.
Dé Tran QH, Guay E, Chartier S, Tousignant J. Dé Tran QH, et al. J Cutan Med Surg. 2001 Jul-Aug;5(4):329-35. doi: 10.1007/s102270000022. Epub 2001 May 2. J Cutan Med Surg. 2001. PMID: 11907845 Review.
Animal studies with the ointment for the prevention of skin graft rejection, lupus dermatoses, and skin papilloma formation have also shown to be promising. CONCLUSIONS: There are case reports of pyoderma gangrenosum, Sezary's syndrome, and Behcet's disease successfully tr …
Animal studies with the ointment for the prevention of skin graft rejection, lupus dermatoses, and skin papilloma formation have also …
Chemotherapy for recurrent/metastatic head and neck cancers.
Karabajakian A, Toussaint P, Neidhardt EM, Paulus V, Saintigny P, Fayette J. Karabajakian A, et al. Anticancer Drugs. 2017 Apr;28(4):357-361. doi: 10.1097/CAD.0000000000000473. Anticancer Drugs. 2017. PMID: 28166090 Review.
Other schemes are currently being compared with this protocol in ongoing trials and the association of cisplatin, docetaxel, and cetuximab appears to be the most efficient. The human papilloma virus is very likely a favorable prognostic factor. Immunotherapy with nivolumab …
Other schemes are currently being compared with this protocol in ongoing trials and the association of cisplatin, docetaxel, and cetuximab a …
ISA101 and nivolumab for HPV-16(+) cancer: updated clinical efficacy and immune correlates of response.
Sousa LG, Rajapakshe K, Rodriguez Canales J, Chin RL, Feng L, Wang Q, Barrese TZ, Massarelli E, William W, Johnson FM, Ferrarotto R, Wistuba I, Coarfa C, Lee J, Wang J, Melief CJM, Curran MA, Glisson BS. Sousa LG, et al. J Immunother Cancer. 2022 Feb;10(2):e004232. doi: 10.1136/jitc-2021-004232. J Immunother Cancer. 2022. PMID: 35193933 Free PMC article. Clinical Trial.
Enrichment in gene sets associated with interferon-gamma response and immune infiltration strongly predicted response to therapy. A randomized trial is ongoing to test this strategy and to further explore correlates of immune response with combined nivolumab and ISA …
Enrichment in gene sets associated with interferon-gamma response and immune infiltration strongly predicted response to therapy. A rando …
2,572 results